We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$78.9B
AUM Growth
+$522M
Cap. Flow
+$1.98B
Cap. Flow %
2.5%
Top 10 Hldgs %
13.37%
Holding
702
New
56
Increased
268
Reduced
333
Closed
31

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$552M
2
BA icon
Boeing
BA
+$226M
3
ORCL icon
Oracle
ORCL
+$190M
4
CB icon
Chubb
CB
+$176M
5
NVS icon
Novartis
NVS
+$172M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Industrials 14.85%
3 Technology 14.38%
4 Healthcare 14.3%
5 Consumer Discretionary 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAY icon
101
Corpay
CPAY
$24.2B
$267M 0.34%
1,022,176
+1,019,413
+36,895% +$264M
BWXT icon
102
BWX Technologies
BWXT
$16B
$262M 0.33%
4,869,774
+188,450
+4% +$10.6M
EQR icon
103
Equity Residential
EQR
$25.4B
$259M 0.33%
3,201,629
+89,751
+3% +$7.41M
PH icon
104
Parker-Hannifin
PH
$125B
$257M 0.33%
919,644
+24,389
+3% +$7.26M
FL
105
DELISTED
Foot Locker
FL
$257M 0.33%
5,619,996
+132,492
+2% +$7.36M
WCC
106
WESCO International
WCC
$16.2B
$256M 0.32%
2,214,055
+31,405
+1% +$3.46M
LRCX icon
107
Lam Research
LRCX
$382B
$255M 0.32%
4,490,120
-12,880
-0.3% -$784K
LDOS icon
108
Leidos
LDOS
$14.1B
$250M 0.32%
2,604,500
+76,686
+3% +$7.6M
BMY icon
109
Bristol-Myers Squibb
BMY
$127B
$246M 0.31%
+4,159,880
New +$274M
CHX
110
DELISTED
ChampionX
CHX
$246M 0.31%
10,973,418
-166,604
-1% -$3.81M
DRE
111
DELISTED
Duke Realty Corp.
DRE
$246M 0.31%
5,140,256
+143,124
+3% +$7.22M
MOH icon
112
Molina Healthcare
MOH
$10.3B
$246M 0.31%
905,656
+21,663
+2% +$5.72M
CRH icon
113
CRH
CRH
$66.7B
$245M 0.31%
5,246,193
+38,402
+0.7% +$1.95M
ELV icon
114
Elevance Health
ELV
$81.9B
$242M 0.31%
647,991
-1,451,782
-69% -$552M
VRT icon
115
Vertiv
VRT
$112B
$241M 0.31%
10,018,760
+76,829
+0.8% +$2.04M
ETR icon
116
Entergy
ETR
$54.1B
$241M 0.31%
4,853,534
+1,437,714
+42% +$77M
REG icon
117
Regency Centers
REG
$15B
$239M 0.3%
3,551,018
+98,634
+3% +$6.53M
ST icon
118
Sensata Technologies
ST
$6.65B
$239M 0.3%
4,359,806
+197,654
+5% +$11.4M
LOW icon
119
Lowe's Companies
LOW
$116B
$237M 0.3%
1,165,469
+7,701
+0.7% +$1.53M
TGNA
120
DELISTED
TEGNA Inc
TGNA
$233M 0.3%
11,832,320
+215,243
+2% +$3.91M
WH icon
121
Wyndham Hotels & Resorts
WH
$5.46B
$232M 0.29%
3,010,496
+87,653
+3% +$6.29M
LHX icon
122
L3Harris
LHX
$55.9B
$225M 0.29%
1,022,015
+27,449
+3% +$6.24M
D icon
123
Dominion Energy
D
$62.5B
$224M 0.28%
3,064,537
-10,154
-0.3% -$774K
SNY icon
124
Sanofi
SNY
$104B
$221M 0.28%
+4,591,184
New +$233M
TMUS icon
125
T-Mobile US
TMUS
$193B
$218M 0.28%
1,706,144
-936,673
-35% -$130M

Similar funds

Boston Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Boston Partners held 702 positions worth $78.9B, up 0.67% from $78.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q3 2021 filing shows 56 new, 268 increased, 333 reduced and 31 closed positions. Its largest new stake was Global Payments: 2,796,841 shares worth $441M. The largest sale was Elevance Health, an estimated $552M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

  • Boston Partners's largest Q3 2021 buy was Global Payments: 2,796,841 shares worth $441M.
  • Boston Partners added most to Activision Blizzard in Q3 2021, an estimated $314M increase.
  • Boston Partners's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $552M.
  • Boston Partners fully exited Cummins in Q3 2021, selling an estimated $161M.
  • Boston Partners's ten largest holdings make up 13% of its $78.9B portfolio in Q3 2021.
  • Boston Partners opened 56 new positions and closed 31 in Q3 2021.
  • Boston Partners's portfolio value rose 0.67% quarter-over-quarter to $78.9B.

Based on Boston Partners's 13F filing for Q3 2021, filed 5 Nov 2021.